Player FMアプリでオフラインにしPlayer FMう!
COVID-19 Therapy Based on AI Pharmaceutical Biotech and Ethnobotanicals with Dr. Saran Saund Oncotelic Therapeutics TRANSCRIPT
Manage episode 280817169 series 99915
Dr. Saran Saund, Chief Business Officer, Oncotelic Therapeutics is an immuno-oncology company dedicated to developing RNA cancer therapies for melanoma and pancreatic cancer using their nano molecular therapy platform. Using AI they recently screened several of their own molecules and ethnobotanicals for COVID-19. As a result Oncotelic has developed a compound based on an ancient ayurvedic artemisinin-based therapy using the active ingredient from the plant artemisia, also known as sweet wormwood. The tablet formulation of ARTIVeda would allow for efficient distribution to a global audience at a fraction of the cost of current therapies like Remdesivir.
#Oncotelic #COVID19 #COVIDTherapies #ARTIVeda
1731 つのエピソード
Manage episode 280817169 series 99915
Dr. Saran Saund, Chief Business Officer, Oncotelic Therapeutics is an immuno-oncology company dedicated to developing RNA cancer therapies for melanoma and pancreatic cancer using their nano molecular therapy platform. Using AI they recently screened several of their own molecules and ethnobotanicals for COVID-19. As a result Oncotelic has developed a compound based on an ancient ayurvedic artemisinin-based therapy using the active ingredient from the plant artemisia, also known as sweet wormwood. The tablet formulation of ARTIVeda would allow for efficient distribution to a global audience at a fraction of the cost of current therapies like Remdesivir.
#Oncotelic #COVID19 #COVIDTherapies #ARTIVeda
1731 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。